Table 1.
Gene targeted | Toxicant |
Time of
Exposure |
Toxicant Effect | MO effect on toxicity | Reference |
---|---|---|---|---|---|
Ahr2 | TCDD | 3-4 hpf | Pericardial edema at 96 hpf | Protected | 24 |
PCB-126 | 8-32 hpf | Pericardial edema at 72 hpf | Protected | 33 | |
FICZ | 48-56 hpf | Non-toxic, induction of Cyp1 genes |
Decreased gene induction |
34 | |
Tri-cyclic PAHs, crude oil |
4-48 hpf | Cardiac dysfunction | No effect | 35 | |
PAHs (pyrene) |
4-48 hpf | Cardiac dysfunction | Protected | ||
PAH (benz[a]ant hracene) |
6-48 hpf | Pericardial edema | Protected | 36 | |
PAHs (BNF, ANF) |
24-96 hpf | Pericardial edema and truncation of Meckel’s cartilage at 72 and 96 hpf |
Protected | 21 | |
Ahr1a | PAH (pyrene) |
6-96 hpf | Pericardial edema and hepatomegaly at 96 hpf |
Protected | 35 |
Cyp1a | PAHs (ANF, BNF) |
24-96 hpf | Pericardial edema and truncation of Meckel’s cartilage at 96 hpf |
Exacerbated | 21 |
TCDD | 4-5 hpf | Pericardial edema and truncation of Meckel’s cartilage at 72 and 96 hpf |
No effect | 22 | |
Cyp1b1 | PAHs (ANF, BNF) |
24-96 hpf | Pericardial edema and truncation of Meckel’s cartilage at 96 hpf |
No effect | 37 |
Arnt1 | TCDD | 3-4 hpf | Pericardial edema at 96 hpf | Protected | 38 |
Arnt2 | TCDD | 3-4 hpf | Pericardial edema at 96 hpf | No effect | 29 |
Ahrra | TCDD | 6 hpf | Pericardial edema at 72 hpf | Exacerbated | 17 |
- | - | - | Mimics TCDD deformities at 72 hpf |
17 | |
Ahrrb | TCDD | 6 hpf | Pericardial edema at 72 hpf | Exacerbated | 17 |
p53 | PCB 126 | 5-24 hpf | Cardiac dysmorphogenesis at 72 hpf |
No effect | 39 |
Sox9b | - | - | - | Mimics TCDD jaw deformities at 72 hpf |
13 |
R-Spondinl | TCDD | 2 dpf | Inhibition of fin regeneration at 2-3 days post amputation (4-5 dpf) |
Protected | 10 |
Nrf2 | tBOOH | 24-96 hpf | Mortality at 96 hpf | Exacerbated | 8 |
tBHQ | 4 dpf | Induction of gstp mRNA | Protected | 30 | |
PFOS | 4-96 hpf | Increased detection of reactive oxygen species (ROS) and expression of antioxidant genes |
Increased ROS detection with DCF- DA probe; reduced induction of HO-1 gene expression |
40 | |
cardiac troponin T | PCB 126 | 5-24 hpf | Cardiac dysmorphogenesis at 72 hpf |
Protected | 39 |
Dopamine transporter (DAT) |
MPTP | 24-96 hpf | Neurodegeneration at 4 dpf | Protected | 41 |
Cox2 | TCDD | 24-50 hpf | Mesencephalic blood flow reduced at 50 hpf |
Protected | 42 |
thromboxane synthase |
TCDD | 24-50 hpf | Mesencephalic blood flow reduced at 50 hpf |
Protected | 42 |
cereblon (CRBN) | - | - | - | Mimics thalidomide toxicity (Exposure 2- 72 hpf results in reduction in size of otic vesicles at 30 hpf, loss or truncation of pectoral fins at 75 hpf,) |
43 |
Cul4a | |||||
PTEN (phosphatase/tensi n homolog)- induced putative kinase (PINKl) |
MPTP | 1-4 dpf | Reduced swimming activity, loss of TH immunoreactivity in cells in the parvocellular pretectal nucleus |
Exacerbated | 28 |